Key result
Cardamonin protected against doxorubicin-induced cardiotoxicity in mice by activating Nrf2 signaling, suppressing oxidative stress and inflammation, and improving cardiac function.
Why the study?
The molecular mechanisms underlying doxorubicin-induced cardiomyopathy are not completely clarified, and disease-specific therapeutic strategies are lacking.
Does cardamonin protect against doxorubicin-induced cardiotoxicity in a mouse model?
Does cardamonin protect against doxorubicin-induced cardiotoxicity in a mouse model?
Answers are grounded in this paper and cite their sources.
Cardamonin demonstrates potential as a therapeutic strategy to prevent doxorubicin-induced cardiomyopathy by activating the Nrf2-related cytoprotective system in a preclinical model.
The clinical application of doxorubicin (DOX) for cancer treatment is limited due to its cardiotoxicity. However, the basic pathophysiological molecular mechanisms underlying DOX-induced cardiomyopathy have not yet been completely clarified, and the disease-specific therapeutic strategies are lacking. The aim of the present study was to investigate the potential cardioprotective effect of cardamonin (CAR), a flavone found in Alpinia plant, on DOX-induced cardiotoxicity in a mouse model. At first, in DOX-treated mouse cardiomyocytes, CAR showed significantly cytoprotective effects through elevating nuclear factor erythroid-2 related factor 2 (Nrf2) signaling, and reducing the degradation of Nrf2. This process then improved the anti-oxidant system, as evidenced by the up-regulated expression levels of haem oxygenase-1 (HO1), NAD(P)H:quinone oxidoreductase 1 (NQO1), glutamate-cysteine ligase modifier subunit (GCLM), superoxide dismutase (SOD), glutathione (GSH) and catalase (CAT). In contrast, DOX-induced increases in malondialdehyde (MDA) and reactive oxygen species (ROS) were highly inhibited by CAR treatments. Additionally, DOX-induced apoptosis and inflammatory response in cardiomyocytes were diminished by CAR through reducing the Caspase-3 and nuclear factor-κB (NF-κB) signaling pathways, respectively. Then, in the DOX-induced animal model with cardiotoxicity, we confirmed that through improving Nrf2 signaling, CAR markedly suppressed oxidative stress, apoptosis and inflammatory response in hearts of mice, improving cardiac function eventually. Together, our findings demonstrated that CAR activated Nrf2-related cytoprotective system, and protected the heart from oxidative damage, apoptosis and inflammatory injury, suggesting that CAR might be a potential therapeutic strategy in the prevention of DOX-associated myocardiopathy.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2019) studied Doxorubicin-induced cardiotoxicity. Cardamonin vs. Doxorubicin alone was evaluated on Oxidative stress, apoptosis, inflammatory response, and cardiac function. Cardamonin protected against doxorubicin-induced cardiotoxicity in mice by activating Nrf2 signaling, suppressing oxidative stress and inflammation, and improving cardiac function.
Synapse has enriched 10 related papers. Consider them for comparative context: